Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
D000818:Animals; D003024:Clozapine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology*; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004347:Drug Interactions; D004983:Ethanolamines / Q000494:pharmacology; D006801:Humans; D008032:Limbic System / Q000502:physiology*; D009434:Neural Pathways / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D009830:Olfactory Bulb / Q000187:drug effects; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000378:metabolism / Q000502:physiology*; D013881:Thioridazine / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D004983:Ethanolamines; D011954:Receptors, Dopamine; D005680:gamma-Aminobutyric Acid; D003024:Clozapine; D013881:Thioridazine; D003913:Dextroamphetamine; D004298:Dopamine